David Fuhrer

Biography

 David Fuhrer has been with the Neopharm Group for over 30 years and has been instrumental in bringing the company to its leading position in the Israeli pharmaceuticals arena. He joined the company in 1980 as Manager of the Veterinary and Chemicals divisions. By 1986, he had assumed the position of Managing Director, and in 1998 he was named Chief Executive Officer. Following the acquisition of Eldan Electronic Instruments LTD., and Promedico LTD., Mr. Fuhrer was appointed Chairman and CEO of the group in 2007. Mr. Fuhrer holds an LLB degree from Tel Aviv University, and is a member of the Israeli Bar. A well-respected figure in Israel’s business and pharmaceutical community, Mr. Fuhrer is actively involved in industry associations. Mr. Fuhrer volunteered to be the Chairman of the Israel Friends of Bar-Ilan University association and in 2009 received an Honorary Doctorate for his contribution to Israel’s pharmaceutical industry. In 2011, he received an honorary fellowship from the Interdisciplinary Center (IDC) in Herzeliya for his contribution to industry and community in Israel.

Research Interest

Pharmaceuticals arena